Clinical Study

Adjuvant Bidirectional Chemotherapy with Intraperitoneal Pemetrexed Combined with Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma

Table 1

Demographic features and outcomes of cytoreductive surgery in ten patients undergoing adjuvant chemotherapy with intraperitoneal pemetrexed and intravenous cisplatin for diffuse malignant peritoneal mesothelioma.

Number of patients

Peritoneal cancer index (PCI)
CC score
 CC 0/14
 CC 24
 CC 32
Visceral sparing cytoreduction8
Colon resection2